Algorhythm Holdings, Inc. (RIME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Kezar Life Sciences (KZR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Investing.com -- Redburn has upgraded EssilorLuxottica to Buy, setting a price target of €320, which implies 21% upside from its current share price as of Tuesday’s close. The analysts cited the ...

Investing can be easy when you use financial ratios for a quick yes/no decisions for your stocks to buy. I'll show you my favorite ratio analysis and reveal three stocks I'm buying right now. Don't ...

We're inching closer to the biggest Social Security announcement of the year, with five of the six data points needed to ...

You must meet eligibility requirements to qualify for Social Security spousal benefits. It's possible to be dually eligible for retirement and spousal benefits, though you'll only get one of the two.